Literature DB >> 2760916

Use of infectious molecular clones of simian immunodeficiency virus for pathogenesis studies.

H W Kestler1, Y N Naidu, T Kodama, N W King, M D Daniel, Y Li, R C Desrosiers.   

Abstract

Three infectious molecular clones of SIVmac and one of HIV-2 exhibit remarkable variation in their biological properties despite similarities in genome organization and sequence relatedness. Cloned viruses differed in their ability to grow in various cultured cells, in their ability to infect macaques, and in the location of the env stop codon. Sequences from the 3' end predict that at least three of the four clones do not have an intact, functional nef gene. All four cloned viruses yield infectious virus in HUT-78 and all four cloned viruses are cytopathic.

Entities:  

Mesh:

Year:  1989        PMID: 2760916

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  8 in total

1.  Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque saliva.

Authors:  Jessica S Thomas; Nedra Lacour; Pamela A Kozlowski; Steve Nelson; Gregory J Bagby; Angela M Amedee
Journal:  AIDS Res Hum Retroviruses       Date:  2010-08       Impact factor: 2.205

2.  Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.

Authors:  A N Vzorov; R W Compans
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.

Authors:  Elena Priceputu; Zaher Hanna; Chunyan Hu; Marie-Chantal Simard; Patrick Vincent; Steffen Wildum; Michael Schindler; Frank Kirchhoff; Paul Jolicoeur
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

4.  Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.

Authors:  Welkin E Johnson; Hannah Sanford; Linda Schwall; Dennis R Burton; Paul W H I Parren; James E Robinson; Ronald C Desrosiers
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Competitive fitness of nevirapine-resistant human immunodeficiency virus type 1 mutants.

Authors:  Jennifer A Collins; M Gregory Thompson; Elijah Paintsil; Melisa Ricketts; Joanna Gedzior; Louis Alexander
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 6.  Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.

Authors:  Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

7.  APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans.

Authors:  Rayhane Nchioua; Dorota Kmiec; Amit Gaba; Christina M Stürzel; Tyson Follack; Stephen Patrick; Andrea Kirmaier; Welkin E Johnson; Beatrice H Hahn; Linda Chelico; Frank Kirchhoff
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

8.  Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives.

Authors:  Rajesh Thippeshappa; Hongmei Ruan; Jason T Kimata
Journal:  Biology (Basel)       Date:  2012-05-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.